Waksal Harlan

Waksal Harlan is listed in filings as Executive Chair at Lyra Therapeutics, Inc.. This profile follows SEC Form 4 activity through Dec 11, 2024, including 1 public disclosure. Recent filings connect the profile to Lyra Therapeutics, Inc. (LYRA). The current snapshot covers public activity from Dec 11, 2024. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.